Home arrow Contact

Company Continues Tests On Nasal Bird Flu Vaccine

PDF Print E-mail
Written by Scott Cosby   
Saturday, 25 August 2007
Tag it:
Delicious
Furl it!
Spurl
NewsVine
Reddit
YahooMyWeb
Technorati
Digg
feedmelinks
Stumble
YahooMyWeb

DelSite Biotechnologies has recently begun animal toxicology studies of its GelVac nasal powder influenza vaccine that includes a bird flu antigen.

Toxicology studies are an important step during the vaccine development and will assess the safety of the vaccine in animals.

The toxicology studies are being conducted at a contract research organization, using study protocols that have been reviewed by the Food and Drug Administration (FDA).

The GelVac nasal powder platform is an in-situ gelling powder formulation based on the company's polymer technologies.

Tag it:
Delicious
Furl it!
Spurl
NewsVine
Reddit
YahooMyWeb
Technorati
Digg
feedmelinks
Stumble
YahooMyWeb
Tags:
Click to add your tags...,
Comments (0) >> feed
Write comment

You must be logged in to a comment. Please register if you do not have an account yet.


busy
 
< Prev   Next >

Login Form






Lost Password?
No account yet? Register

Syndicate